Combinaisons thérapeutiques d'anticorps anti-igfr1
- 专利权人:
- MERCK SHARP & DOHME CORP.
- 发明人:
- 申请号:
- EP10160260.5
- 公开号:
- EP2230254B1
- 申请日:
- 2004.11.19
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要:
- The present invention provides combinations including a binding composition, such as an anti-IGFR1 antibody, in association with a chemotherapeutic agent. Methods for using the combinations to treat medical conditions, such as cancer, are also provided.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- ANTI-CD22 ANTIBODY-MAYTANSINE CONJUGATES, COMBINATIONS, AND METHODS OF USE THEREOF
- Anti-CD22 antibody-maytansine conjugates, combinations, and methods of use thereof
- DIAGNOSIS OF TREATMENT OF CANCER USING ANTI-TM4SF20 ANTIBODY
- Treatment of lung cancer using a combination of anti-PD-1 antibody and another anticancer agent
- PHARMACEUTICAL AGENT FOR TREATMENT AND/OR PREVENTION OF CANCER